Home/Filings/4/0001209191-18-039187
4//SEC Filing

Schwieterman William D 4

Accession 0001209191-18-039187

CIK 0000908259other

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 4:17 PM ET

Size

8.5 KB

Accession

0001209191-18-039187

Insider Transaction Report

Form 4
Period: 2018-06-20
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-06-20+500,000500,000 total
    Exercise: $0.22Exp: 2028-06-20Common Stock (500,000 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2018-06-20+500,000500,000 total
    Exercise: $0.22Exp: 2028-06-20Common Stock (500,000 underlying)
Footnotes (3)
  • [F1]Dr. Schwieterman was awarded options to purchase Mateon Therapeutics, Inc. common stock, $0.01 par value per share (the "2017 Plan Options"), pursuant to the Mateon Therapeutics, Inc. 2017 Equity Incentive Plan in connection with his service as President and Chief Executive Officer.
  • [F2]The Options will vest in twelve equal monthly installments beginning one month after the date of grant.
  • [F3]Dr. Schwieterman was awarded options to purchase Mateon Therapeutics, Inc. common stock, $0.01 par value per share (the "2015 Plan Options" and, collectively with the 2017 Plan Options, the "Options"), pursuant to the Amended and Restated Mateon Therapeutics, Inc. 2015 Equity Incentive Plan in connection with his service as President and Chief Executive Officer.

Issuer

MATEON THERAPEUTICS INC

CIK 0000908259

Entity typeother

Related Parties

1
  • filerCIK 0001403961

Filing Metadata

Form type
4
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:17 PM ET
Size
8.5 KB